Home Tags Pharmaceuticals
Belviq was first approved by the FDA in 2012 and works by making people feel fuller than they actually are. It was never approved for use in Canada.
Pharma stocks plunged after federal prosecutors launched a criminal probe into their role in fueling the opioid crisis
Traders wiped more than $3 billion from the market caps of five drug companies after learning they received grand jury subpoenas.
‘Insta-billionaire’: A 24-year-old pharma heir who parties with celebrities became richer than Donald Trump overnight
Eric Tse — who has snapped photos with Rihanna, Bella Hadid, and Yao Ming — was gifted a stake in his parents' company worth $3.8 billion.
One chart reveals how the cost of insulin has skyrocketed in the US, even though nothing about it has changed
The price of insulin has tripled in the past 10 years, and people with diabetes across the US are struggling to afford the drug that keeps them alive.
Joe Biden reportedly praised pharmaceutical companies at a private party despite publicly railing against high drug prices
Biden told donors in private that there were "great drug companies out there — except a couple of opioid outfits," according to Bloomberg.
Americans hate big pharma more than they do the government (but they still really dislike the government)
The pharmaceutical industry ranks below all other public and private sectors in favorability among Americans, according to a new Gallup poll.
Can you tell which is fake?
Sarepta tumbles after the FDA rejects its muscular dystrophy treatment — a decision that left the CEO ‘very surprised’
The FDA cited risk of IV infection and kidney toxicity in its letter. The company's CEO said the FDA issued no prior warning for the two concerns.
A judge just massively cut a $2 billion jury payout to a couple who claimed Bayer’s Roundup weedkiller caused their cancer
Bayer, facing lawsuits from more than 13,000 farmers, landscapers, and gardeners, has successfully reduced three jury awards in the past year.
The indictment says the charges were necessary to combat the company's profits from vulnerable areas that are the hardest-hit by the opioid epidemic.